10 brands that really need to rebrand in 2025
Even the most iconic brand occasionally finds itself at a crossroads. A strong identity can keep you relevant for decades, ...
Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
A next-gen Ozempic falls short in a drug trial — and Novo Nordisk stock plunges 20%
Novo Nordisk (NVO) released mixed clinical-trial results for its potential Ozempic successor on Friday, leaving Wall Street ...
Novo Nordisk stock sees biggest loss in more than 20 years on CagriSema results
Failed to fetch dynamically imported module: https://uk.finance.yahoo.com/assets/_app/immutable/nodes/95.DUSyTeHW.js ...
Is Eli Lilly and Company (LLY) the Best Low Volatility Stock to Buy Right Now?
We recently published a list of 8 Best Low Volatility Stocks To Buy Right Now. In this article, we are going to take a look ...
israelnewsonline28d
Eli Lilly's Obesity Drug Beats Rivals Head-to-Head – Cramer Expects Shares to Rise Next
Zepbound's active ingredient tirzepatide also targets a second ... NO SPECIFIC RESULTS OR PROFITS ARE GUARANTEED. A sign with the company logo stands in front of the Eli Lilly and Company headquarters ...
Eli Lilly's Zepbound Drug Likely To Dominate Global Obesity Market: Report
Eli Lilly's Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and strategic ...
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
NDTV5d
Eli Lilly's Zepbound Drug Likely To Dominate Global Obesity Market: Report
Zepbound, as expected, was more effective in promoting weight loss. Eli Lilly's Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and strategic ...
Business Insider12d
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...
Today8d
NBA Hall of Famer Isiah Thomas reveals Bell’s palsy diagnosis
NBA Hall of Famer Isiah Thomas announced Thursday that he has been diagnosed with Bell’s palsy. “I’ve gotten a lot of love ...
Jimmy Carter and his wife, Rosalynn, were married 77 years. Their 6 marriage secrets
The couple fell in love when they were teenagers and had an enduring romance into their 90s. Here's how they kept their relationship strong for decades.